T-1105
目录号: PL06400 纯度: ≥99%
CAS No. :55321-99-8
商品编号 规格 价格 会员价 是否有货 数量
PL06400-100mg 100mg ¥803.00 请登录
PL06400-200mg 200mg 询价 询价
PL06400-500mg 500mg 询价 询价
PL06400-10mM*1mLinDMSO 10mM*1mLinDMSO ¥884.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
T-1105
中文别名
3-羟基吡嗪-2-酰胺;3-羟基吡嗪-2-甲酰胺;2-羟基-3-酰胺吡嗪;3-Hydroxypyrazine-2-carboxamide 3-羟基吡嗪-2-甲酰胺;3-羟基吡嗪-2-羧胺;3-羟基吡嗪-2-酰胺,3-HYDROXYPYRAZINE-2-CARBOXAMIDE;3-羟基吡嗪-2-酰胺,98;法匹拉韦中间体;硼烷 -5-乙基-2-甲基吡啶络合物;5-(N-羟乙基)氨基邻甲酚
英文名称
T-1105
英文别名
3-Hydroxypyrazine-2-carboxamide;3-HYDROXYPYRAZINE-2-CARBOXAMINE;2-oxo-1H-pyrazine-3-carboxamide;3,4-Dihydro-3-oxo-2-pyrazinecarboxamide;T-1105
Cas No.
55321-99-8
分子式
C5H5N3O2
分子量
139.11
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
T-1105,T-705 的结构类似物,是一种广谱 病毒聚合酶 (polymerase) 抑制剂。T-1105 在转化为核糖核苷三磷酸 (RTP) 代谢物后抑制 RNA 病毒的聚合酶。T-1105 对各种 RNA 病毒表现出抗病毒活性,T-1105 可由烟酰胺单核苷酸腺苷酰转移酶形成。
生物活性
T-1105, a structural analogue of T-705, is a novel broad-spectrum viral polymerase inhibitor. T-1105 inhibits the polymerases of RNA viruses after being converted to ribonucleoside triphosphate (RTP) metabolite. T-1105 has antiviral activity against various RNA viruses. T-1105 can be formed by nicotinamide mononucleotide adenylyltransferase.
性状
Solid
IC50 & Target[1][2]
EC50: 17 μM (parainfluenza-3 virus); EC50: 24 μM (Punta Toro virus) .
EC50: 97.5 μM (ZIKV strain SZ01)
体外研究(In Vitro)
T-1105 has antiviral activity against various RNA viruses, including Zika virus (ZIKV), influenza virus, arenaviruses, bunyaviruses, West Nile virus (WNV), yellow fever virus (YFV), and foot-and-mouth disease virus (FMDV).
T-1105 has good anti-RNA virus activity with values EC50 of 17 μM and 24 μM for parainfluenza-3 virus and Punta Toro virus in MDCK cells.
T-1105 is a potential inhibitor of Zika virus replication.
T-1105 can inhibit the SFTSV replication with an value IC50 of 49 μM in Vero cells and is not affect cell viability in 0-3 μM. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
T-1105 (Oral, 200 mg/kg, twice daily for 6 days) effectively inhibits the virus replication in the infected pigs. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Pigs
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Huchting J, et al. Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir). Antiviral Res. 2019 Jul;167:1-5.
[2]. Furuta Y, et al. T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections. Antiviral Res. 2009 Jun;82(3):95-102.
溶解度数据
In Vitro: DMSO : 25 mg/mL (179.71 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2